Nonnucleoside inhibitors of HIV-1 reverse transcriptase: from the biology of reverse transcription to molecular design.
about
Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitorsA novel small molecular weight compound with a carbazole structure that demonstrates potent human immunodeficiency virus type-1 integrase inhibitory activity.Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.Synthesis and biological evaluation of 2-thioxopyrimidin-4(1H)-one derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile.The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes.Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010).Molecular insight on the binding of NNRTI to K103N mutated HIV-1 RT: molecular dynamics simulations and dynamic pharmacophore analysis.Profile of disposition, tissue distribution and excretion of the novel anti-human immunodeficiency virus (HIV) agent W-1 in rats.Searching for novel scaffold of triazole non-nucleoside inhibitors of HIV-1 reverse transcriptase.Development of a liposomal nanodelivery system for nevirapineInvestigation of novel lipid-functionalized PNA monomers as potential HIV-1 non-nucleoside reverse transcriptase and/or integrase inhibitors.Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs.Synthesis and biological evaluation of new conformationally restricted S-DABO hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
P2860
Q26777448-CAE9388B-6094-4482-8CCA-AF0D59913FECQ33228536-DFF18F3C-EADE-4520-AEFD-A226A9ED5315Q34062476-2C8243C7-24A7-4B6D-897F-FD78568ED3EBQ34163065-E242FA35-E858-4B63-8148-D259ADDA3F59Q34685500-BE5FC723-00E1-4010-BEC5-33734E38F887Q35851936-5D270709-DE45-4479-8FC1-35D8C50AA857Q35859896-6E38E6F4-C30B-4A58-9900-364BE9818654Q37860335-936FB8CB-F3DD-4D59-9D67-B929F2A4B08EQ39306655-6CB2FE05-F266-4DB3-BE43-C9CE4949C2C3Q40708931-A8998E09-9760-4C19-B531-DD8A6C5622D6Q42144118-E3D4CDDF-AD5C-42FD-85B1-98D4F6E1DE9CQ42242819-9BC17C95-8EF6-4E2F-A69F-0022AA132A68Q46866790-9EB2755E-4D74-41A9-BEAB-2823B0807D2EQ54320660-1A9CD42D-AE6C-42CF-ABB0-E100A89C5398Q57269187-52FD2829-DFF4-45C2-BEBC-B6444185C18A
P2860
Nonnucleoside inhibitors of HIV-1 reverse transcriptase: from the biology of reverse transcription to molecular design.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Nonnucleoside inhibitors of HI ...... scription to molecular design.
@ast
Nonnucleoside inhibitors of HI ...... scription to molecular design.
@en
type
label
Nonnucleoside inhibitors of HI ...... scription to molecular design.
@ast
Nonnucleoside inhibitors of HI ...... scription to molecular design.
@en
prefLabel
Nonnucleoside inhibitors of HI ...... scription to molecular design.
@ast
Nonnucleoside inhibitors of HI ...... scription to molecular design.
@en
P356
P1476
Nonnucleoside inhibitors of HI ...... scription to molecular design.
@en
P2093
Jean M J Tronchet
Michel Seman
P304
P356
10.2174/1568026033451754
P577
2003-01-01T00:00:00Z